Test Price
2,800 AED✅ Home Collection Available
ATP1A3 Gene CAPOS Syndrome Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
- Diagnostic Precision: 99.9% analytical sensitivity and specificity via ISO 15189:2022 accredited next-generation sequencing with full ATP1A3 gene coverage.
- Premium Logistics: VIP mobile phlebotomy and temperature-controlled cold-chain home collection available daily 8 AM – 11 PM across all UAE emirates.
- Genetic Counselling: Mandatory pre‑ and post‑test counselling session with a DHA‑registered consultant medical geneticist included.
- Insurance Verification: Direct coverage check via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced genetic test provides a definitive molecular diagnosis for Cerebellar Ataxia, Areflexia, Pes Cavus, Optic Atrophy, and Sensorineural Hearing Loss (CAPOS) syndrome by detecting pathogenic variants in the ATP1A3 gene. Next‑generation sequencing (NGS) ensures comprehensive variant calling with full gene coverage, eliminating detection gaps common in traditional Sanger sequencing.
| Feature | DNA Labs UAE Test | Closest Alternative |
|---|---|---|
| Precision | 99.9% analytical sensitivity and specificity via NGS with full gene coverage | Limited panel or Sanger sequencing with potential detection gaps |
| Methodology | NGS (Illumina NovaSeq X Plus) with comprehensive variant calling | Single‑gene Sanger sequencing or outdated NGS kits |
| Turnaround Time | 3–4 weeks | 6–8 weeks or more |
Physician Insight & Safety Protocols
“As a DHA‑licensed consultant medical geneticist, I emphasise that this test is a powerful diagnostic tool but must be interpreted alongside clinical findings and family history. A negative result does not exclude other ataxias or neurological disorders. Any positive finding should be reviewed with a genetic counsellor to fully understand implications for treatment and family planning. Always consult your physician before making changes to your healthcare plan.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration 9294403
Important Safety Advisory
Do not discontinue any prescribed medication without consulting your treating doctor. This genetic test is a diagnostic aid and does not replace ongoing clinical management or emergency care.
Patient Safety Exclusion Criteria & Red Flags
- Not suitable for individuals who cannot provide a sufficient DNA sample (e.g., severe leukopenia).
- Incorrect sample handling (e.g., non‑refrigerated transport) may lead to test cancellation.
- Sudden onset of severe dystonia, loss of consciousness, or acute hearing loss — seek immediate emergency medical attention before proceeding with genetic testing.
Patient FAQ & Clinical Guidance
1. What is the clinical significance of this test?
This NGS test provides a definitive molecular diagnosis for CAPOS syndrome by detecting pathogenic variants in the ATP1A3 gene. It helps guide personalised neurological care, genetic counselling, and family planning decisions.
2. How does the home collection and cold‑chain logistics work?
Our ISO‑certified VIP mobile phlebotomy service collects your blood sample at your doorstep with strict cold‑chain adherence. The service is available daily from 8 AM to 11 PM, covering all areas of the UAE.
3. Is genetic counselling included in the 2,800 AED package?
Yes, a mandatory pre‑ and post‑test genetic counselling session with a DHA‑registered consultant medical geneticist is included to interpret your family history (pedigree) and guide clinical decisions.
UAE Regulatory & Data Privacy Adherence
⚖️ Regulatory Compliance
All patient data is processed in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability. The laboratory holds a DHA Facility License (No. 1143) and is ISO 15189:2022 accredited.
Clinical & Logistical Metadata
| Test Name | ATP1A3 Gene (CAPOS Syndrome) Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole Blood (Peripheral Venous) – VIP Mobile Phlebotomy & Cold‑Chain Home Collection |
| Methodology Used | Next‑Generation Sequencing (NGS) on Illumina NovaSeq X Plus |
| ICD‑10‑CM Code | G11.8 |
| LOINC Code | 79003-5 |
| DHA Facility License & Laboratory Address | License 1143 – DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians